Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers RRM1, TUBB3, and ERCC1

Prospective Clinical Study of Postoperative Individualized Adjuvant Chemotherapy for Patients with Non-Small-Cell Lung Cancer Based on mRNA Expression of the Molecular Markers RRM1, TUBB3, and ERCC1

Objective. To investigate the clinical significance of the mRNA expression of RRM1, TUBB3, and ERCC1 in non-small-cell lung cancer (NSCLC) tissues for the selection of adjuvant/postoperative chemotherapy regimens. Methods. Patients diagnosed with stage Ib-IIIa NSCLC were enrolled and randomly divide...

Full description

Bibliographic Details
Main Authors:	Jingyao Li, Yang Qiu, Junxiu Yi, Xi Liu, Shixin Zhang, Deli Tan, Tao Jing, Yi Liao, Meng Tang, Jie Liu, Haidong Wang
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2021/8820691

Similar Items

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
by: Leng Xue-Feng, et al.
Published: (2012-03-01)

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer
by: Lina Carvalho, et al.
Published: (2009-08-01)

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar
by: Lina Carvalho, et al.
Published: (2009-07-01)

Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage Ⅰ-Ⅱ Lung Cancer
by: Baohui HAN, et al.
Published: (2009-05-01)

Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
by: Khushbu Khetan, et al.
Published: (2021-01-01)

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
by: Valsecchi Matias E, et al.
Published: (2012-03-01)

Effects of Expression of ERCC1, RRM1 on Survival Trend of Lung Cancer with Cisplatin Combine Gemcitabine Chemotherapy after Surgical Resection
by: Min SONG, et al.
Published: (2009-05-01)

Clinical Significance of ERCC1, RRM1 and TS in Non–small Cell Lung Cancer
by: Pei LI, et al.
Published: (2014-06-01)

ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
by: Sun Jong-Mu, et al.
Published: (2012-05-01)

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
by: Andreas-Claudius Hoffmann, et al.
Published: (2010-08-01)

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
by: Tantraworasin A, et al.
Published: (2013-10-01)

Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
by: Yaqiong Zhan, et al.
Published: (2021-01-01)

Polymorphisms in ERCC5 rs17655 and ERCC1 rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy
by: Thomas Senghore, et al.
Published: (2019-01-01)

ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
by: Yangkai Li, et al.
Published: (2013-01-01)

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
by: Wendy Muñoz-Montaño, et al.
Published: (2021-08-01)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
by: Chen L, et al.
Published: (2016-11-01)

Real-Time PCR Data Processing Shown by the Analysis of Colorectal Specific Candidate Genes, ERCC1, RRM1 and TS in Relation to β2M as Endogenous Control
by: Melanie Demes, et al.
Published: (2012-02-01)

expression of RRM1 in cancer cells
by: Ya-Wen Hung, et al.
Published: (2013)

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
by: Ioannis Boukovinas, et al.
Published: (2008-01-01)

GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
by: Maheedhara R. Guda, et al.
Published: (2019-09-01)

Increased mRNA expression levels of <it>ERCC1</it>, <it>OGG1 </it>and <it>RAI </it>in colorectal adenomas and carcinomas
by: Hansteen Inger-Lise, et al.
Published: (2006-08-01)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
by: Song WH, et al.
Published: (2016-06-01)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
by: Wang Tingting, et al.
Published: (2008-04-01)

Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis
by: Haiguang Zhang, et al.
Published: (2017-04-01)

Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.
by: Xiaopeng Dong, et al.
Published: (2014-01-01)

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
by: Ning Tang, et al.
Published: (2017-06-01)

ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.
by: Xiaobo Lu, et al.
Published: (2013-01-01)

TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
by: Athanasia Stoupa, et al.
Published: (2018-12-01)

Correlation of ERCC1 and GSTP1 expression in esophageal cancer tissue with platinum-based chemotherapy sensitivity as well as apoptosis and proliferation gene expression
by: Xiao-Quan Ding, et al.
Published: (2017-06-01)

Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells <it>in vitro </it>and <it>in vivo</it>: implication of RRM2 in angiogenesis
by: Zhou Bingsen, et al.
Published: (2009-02-01)

Correction of ERCC1 deficiency in mice
by: Selfridge, Jim
Published: (1999)

Effect of Y-box binding protein 1 overexpression on the prognosis of patients with intrahepatic cholangiocarcinoma undergoing postoperative adjuvant chemotherapy
by: LIU Heng, et al.
Published: (2017-02-01)

TUBB3: Neuronal Marker or Melanocyte Mimic?
by: Heiko Locher, et al.
Published: (2014-11-01)

Stewart Tubbs: Human communication: Principles and contexts
by: Mirkov Lidija
Published: (2017-01-01)

Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer
by: Tsuyoshi Shinohara, et al.
Published: (2013-01-01)

Evaluation von ERCC1 als prädiktiver Biomarker bei mit platinbasierter Chemotherapie behandeltem Nebennierenrindenkarzinom
by: Laufs, Valeria
Published: (2019)

The Coordination of Netrin Signal Transduction via TUBB3 and JNK1 in Axon Guidance
by: Qu, Chao
Published: (2013)

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy
by: Yan Hong-Hong, et al.
Published: (2010-03-01)

Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
by: Hadeel Obiedat, et al.
Published: (2018-07-01)